| Eric Joseph Clark, DDS | |
|
500 N Broadway, #4, Blythe, CA 92225-1279 | |
| (760) 922-0266 | |
| (760) 922-1066 |
| Full Name | Eric Joseph Clark |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 500 N Broadway, Blythe, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083824478 | NPI | - | NPPES |
| B3840701 | Other | CA | DENTIST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 38407 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eric Joseph Clark, DDS 500 N Broadway, #4, Blythe, CA 92225-1279 Ph: (760) 922-0266 | Eric Joseph Clark, DDS 500 N Broadway, #4, Blythe, CA 92225-1279 Ph: (760) 922-0266 |
News Archive
Data from one of the few head-to-head trials in rheumatoid arthritis (RA) presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that at one year, 64.8% of patients receiving abatacept (Orencia) and 63.4% of patients receiving adalimumab (Humira) achieved ACR20.
Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million.
The global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution of a wide portfolio of minimally invasive medical devices primarily for the treatment of urological diseases, announced the transfer of US clinical study responsibilities and conclusion of its management succession plan announced December 2006.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer therapies, and Lonza, today announced the signing of a process development and scale-up agreement relating to the manufacture of Contego™, Genesis Biopharma's autologous cell therapy product candidate for the treatment of Stage IV metastatic melanoma.
Biovest International, Inc. today announced that the Company filed its proposed Plan of Reorganization with the U.S. Bankruptcy Court for the Middle District of Florida, Tampa Division. With this filing, Biovest is positioned to emerge from Chapter 11 protection this summer as a fully restructured company.
› Verified 8 days ago
Dr. Mueni Lorraine Mutinga, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 19025 Wileys Well Rd, Blythe, CA 92225 Phone: 760-922-5300 | |
Dr. Victor Khalil, Dentist Medicare: Not Enrolled in Medicare Practice Location: 19005 Wileys Well Rd, Blythe, CA 92225 Phone: 760-921-7548 | |
Mr. Carman Stuart Sutley, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 17611 S C & D Blvd, #18, Blythe, CA 92225 Phone: 760-921-2414 Fax: 760-921-2414 | |
Dr. Tiffany Elaine Wade, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 146 S Broadway, Blythe, CA 92225 Phone: 760-567-7873 | |
Hemantkumar Patel, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Hobsonway, Blythe, CA 92225 Phone: 760-922-4981 Fax: 760-922-4442 | |
Dr. Philip Maldonado, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 19025 Wileys Well Rd, Blythe, CA 92225 Phone: 760-922-5300 Fax: 714-992-0759 |